Cite
MLA Citation
P. Strati et al.. “P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL.” HemaSphere, vol. 6, n.d., pp. 1019–1020. http://access.bl.uk/ark:/81055/vdc_100159756034.0x000011